Pengzhou Kong

2.0k total citations
29 papers, 360 citations indexed

About

Pengzhou Kong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pengzhou Kong has authored 29 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Pengzhou Kong's work include RNA modifications and cancer (8 papers), Cancer-related gene regulation (8 papers) and Epigenetics and DNA Methylation (5 papers). Pengzhou Kong is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related gene regulation (8 papers) and Epigenetics and DNA Methylation (5 papers). Pengzhou Kong collaborates with scholars based in China, Hong Kong and United States. Pengzhou Kong's co-authors include Yongping Cui, Xiaolong Cheng, Yu Qian, Heyang Cui, Yanchun Ma, Ting Yan, Ruyi Shi, Yanghui Bi, Caixia Cheng and Xiaolong Cheng and has published in prestigious journals such as Frontiers in Immunology, European Journal of Pharmacology and Cell Death and Disease.

In The Last Decade

Pengzhou Kong

27 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengzhou Kong China 13 257 105 95 45 42 29 360
Cuijuan Qian China 13 300 1.2× 141 1.3× 89 0.9× 34 0.8× 24 0.6× 25 406
Chun‐Wen Su Taiwan 13 316 1.2× 168 1.6× 101 1.1× 40 0.9× 51 1.2× 24 486
Junfang Lyu Macao 11 258 1.0× 107 1.0× 91 1.0× 48 1.1× 34 0.8× 14 384
Shilun Tong China 11 256 1.0× 215 2.0× 99 1.0× 41 0.9× 20 0.5× 25 415
Zhenqing Sun China 13 254 1.0× 123 1.2× 109 1.1× 60 1.3× 60 1.4× 22 445
Yantao Cai China 13 210 0.8× 90 0.9× 123 1.3× 69 1.5× 44 1.0× 28 399
Shibo Yu China 10 175 0.7× 124 1.2× 92 1.0× 112 2.5× 42 1.0× 26 367
Tianwei Chen China 11 247 1.0× 133 1.3× 87 0.9× 53 1.2× 39 0.9× 25 421
Zhen Zhu China 12 268 1.0× 124 1.2× 113 1.2× 70 1.6× 61 1.5× 23 464

Countries citing papers authored by Pengzhou Kong

Since Specialization
Citations

This map shows the geographic impact of Pengzhou Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengzhou Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengzhou Kong more than expected).

Fields of papers citing papers by Pengzhou Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengzhou Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengzhou Kong. The network helps show where Pengzhou Kong may publish in the future.

Co-authorship network of co-authors of Pengzhou Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Pengzhou Kong. A scholar is included among the top collaborators of Pengzhou Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengzhou Kong. Pengzhou Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ye, Jiao, Yingying Zhang, Meng Sun, et al.. (2024). Oseltamivir enhances 5-FU sensitivity in esophageal squamous carcinoma with high SPNS1. Biomedicine & Pharmacotherapy. 173. 116367–116367. 3 indexed citations
3.
Liu, Yang, et al.. (2024). KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5‐Mediated Tryptophan Metabolism. Journal of Cellular and Molecular Medicine. 28(23). e70245–e70245. 5 indexed citations
4.
Ren, Jing, Pengzhou Kong, Yanqiang Wang, Dawei Guo, & Ling Zhang. (2023). Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers (Review). Oncology Reports. 51(1). 1 indexed citations
5.
Zhao, Yujing, Juan Wu, Shuai Guan, et al.. (2023). PIF1 Promotes Autophagy to Inhibit Chronic Hypoxia Induced Apoptosis of Pulmonary Artery Endothelial Cells. International Journal of COPD. Volume 18. 1319–1332. 3 indexed citations
6.
Kong, Pengzhou, Xin Yang, Yingying Zhang, et al.. (2022). Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer. Journal of Oncology. 2022. 1–14. 10 indexed citations
7.
Xu, Xiaoqin, Xin Yang, Xue Liu, et al.. (2022). The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 21. 2213824993–2213824993. 3 indexed citations
8.
Zou, Binbin, et al.. (2022). Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma. Frontiers in Molecular Biosciences. 8. 792779–792779. 8 indexed citations
9.
Yang, Xin, Heyang Cui, Yanchun Ma, et al.. (2022). An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma. Journal of Translational Medicine. 20(1). 285–285. 10 indexed citations
10.
Zhai, Yuanfang, Pengzhou Kong, Ling Zhang, et al.. (2022). FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma. Molecular and Cellular Biochemistry. 477(12). 2689–2702. 18 indexed citations
11.
Wu, Juan, Ru Chen, Yu Qian, et al.. (2021). Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 626605–626605. 2 indexed citations
12.
Chen, Ru, Juan Wu, Chang Lu, et al.. (2021). Systematic Transcriptome Analysis Reveals the Inhibitory Function of Cinnamaldehyde in Non-Small Cell Lung Cancer. Frontiers in Pharmacology. 11. 611060–611060. 22 indexed citations
13.
Zhang, Ling, Xiaojuan Zhang, Min Guo, et al.. (2020). TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 10(24). 11339–11358. 19 indexed citations
14.
Qian, Yu, Pengzhou Kong, Yikun Cheng, et al.. (2020). Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma. Cell Death and Disease. 11(10). 862–862. 28 indexed citations
15.
Li, Qiu, Linfei Hu, Huijuan Wang, et al.. (2020). FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer. Cell Death and Disease. 11(10). 839–839. 7 indexed citations
16.
Yang, Bin, Huijuan Liu, Yanghui Bi, et al.. (2020). MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma. International Journal of Medical Sciences. 17(13). 2013–2023. 27 indexed citations
17.
Kong, Pengzhou, Enwei Xu, Yanghui Bi, et al.. (2020). Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC. Theranostics. 10(4). 1798–1813. 28 indexed citations
18.
Ma, Yanchun, Yi Wang, Lu Wang, et al.. (2019). Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway. European Journal of Pharmacology. 851. 43–51. 40 indexed citations
19.
Hu, Xiao, Yuanfang Zhai, Ruyi Shi, et al.. (2018). FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma. Oncology Reports. 39(5). 2136–2146. 23 indexed citations
20.
Li, Yaoping, et al.. (2017). Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis. Tumor Biology. 39(6). 3726132220–3726132220. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cuijuan Qian Breakdown of academic impact, for papers by Chun‐Wen Su Breakdown of academic impact, for papers by Junfang Lyu Breakdown of academic impact, for papers by Shilun Tong Breakdown of academic impact, for papers by Zhenqing Sun Breakdown of academic impact, for papers by Yantao Cai Breakdown of academic impact, for papers by Shibo Yu Breakdown of academic impact, for papers by Tianwei Chen Breakdown of academic impact, for papers by Zhen Zhu
Rankless by CCL
2026